“…Despite decades of treatment innovation and research, rates of treatment non-response for individuals with disorders such as depression or schizophrenia approaches 50% of all patients Newnham et al, 2007Newnham et al, , 2010Rush and Trivedi, 1995;Rush et al, 2006;Stroup et al, 2006;Thase et al, 2007). While major depressive disorder (MDD) continues to be among the most prevalent psychiatric disorders worldwide (Bromet et al, 2011) symptoms of depression are so pervasive among individuals with psychiatric disorders in general that depression severity has been identified as a cross-cutting domain of psychopathology (L€ owe et al, 2008) and has been included as a DSM-5 cross-cutting measure of psychopathology (Narrow et al, 2013).…”